Erythropoietin Market in Japan 2015-2019 - New Market Report

Erythropoietin (EPO), also referred to as hematopoietin or hemopoietin, is a glycoprotein that is responsible for the production of erythrocytes in the body. In the fetal stage, this protein is produced in the liver. However, in adulthood it is produced in the kidneys. During anemic conditions, the body produces an excess of erythropoietin to maintain a normal level of red blood cells. When the endogenous production of erythropoietin is disrupted because of illness or medications, normal red blood cell levels are maintained by an injecting erythropoiesis-stimulating agents (ESAs). These agents are similar to natural erythropoietin in structure and function. They can be produced by recombinant DNA technology and are used in the treatment of anemia resulting from renal disease, cancer, HIV, injuries, or neurological conditions.

Full Report Details at
- http://www.fastmr.com/prod/1046817_erythropoietin_japan_20152019.aspx?afid=301

Technavio's analysts forecast the erythropoietin market in Japan to decline at a CAGR of (1.16) % over the period 2014-2019.

Covered in this report
In this report, Technavio covers the present scenario and growth prospects of the erythropoietin market in Japan for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of erythropoietin drugs and biosimilars used in the treatment of anemia due to renal disease, chemotherapy, antiretroviral therapy, wounds, or neurological conditions.

Technavio's report, Erythropoietin Market in Japan 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the erythropoietin market in Japan and its growth prospects in the coming years. The report includes a discussion on the key vendors operating in this market.

Key vendors

* Chugai Pharmaceutical
* JCR Pharmaceuticals
* Kissei Pharmaceutical
* Kyowa Hakko Kirin

Other prominent vendors

* Eisai
* Otsuka
* Taiho Pharmaceutical
* Takeda

Market driver

* Increased incidence of anemia due to illness
* For a full, detailed list, view our report

Market challenge

* High cost of therapy
* For a full, detailed list, view our report

Market trend

* Strategic alliances
* For a full, detailed list, view our report

Key questions answered in this report

* What will the market size be in 2019 and what will the growth rate be?
* What are the key market trends?
* What is driving this market?
* What are the challenges to market growth?
* Who are the key vendors in this market space?
* What are the market opportunities and threats faced by the key vendors?
* What are the strengths and weaknesses of the key vendors?

Companies Mentioned in this Report: Chugai Pharmaceutical, JCR Pharmaceuticals, Kissei Pharmaceutical, Kyowa Hakko Kirin

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- The National Institute of Diabetes and Digestive and Kidney Diseases - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- Pfizer Inc. (PFE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- Frontier Pharma: Versatile Innovation in Oncology - Identifying and Commercializing Versatile First-in-Class Innovation
- Protein Engineering Market - Global Forecast to 2020
- Biosimilars Market - Global Forecast to 2020